WuXi ATU Announces Launch of TESSA™ Technology to Improve Scalability and Accessibility of Cell and Gene Therapies medindia.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medindia.net Daily Mail and Mail on Sunday newspapers.
TESSA™ technology provides a scalable process for manufacturing gene therapies, accelerating the production of large quantities of therapeutic DNA required to treat patients in need.
TESSA™ technology provides a scalable process for manufacturing gene therapies, accelerating the production of large quantities of therapeutic DNA required to treat patients in need New data published in Nature Communications supports the benefits of this technology PHILADELPHIA, March 8, 2022 /PRNewswire/ WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, today announced the launch.
/PRNewswire/ InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Global Cell and Gene Therapy Bioassay Services.
JERSEY CITY, N.J., March 3, 2022 /PRNewswire/ InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Global Cell and Gene Therapy Bioassay Services Market